Pulsed 630 nm LED Photobiomodulation Therapy for Primary Dysmenorrhea: A Prospective Randomized Cross-Over Trial

Research Overview

• Title: Bypassing the Heat Risk and Efficacy Limitations of Pulsed 630 nm LED Photobiomodulation Therapy for Anti-Primary Dysmenorrhea: A Prospective Randomized Cross-Over Trial.
• Source: Mdpi

Summary of Key Findings

• Background:Primary Dysmenorrhea (PD) affects up to 90% of young women, primarily caused by excessive prostaglandin release leading to intense uterine contractions.Conventional treatments like NSAIDs often have side effects, while traditional heat patches offer limited relief (around 20%).Existing continuous-wave (CW) red light therapies face a "trade-off": low intensity lacks penetration depth, while high intensity risks skin burns.
  • Primary Dysmenorrhea (PD) affects up to 90% of young women, primarily caused by excessive prostaglandin release leading to intense uterine contractions.
  • Conventional treatments like NSAIDs often have side effects, while traditional heat patches offer limited relief (around 20%).
  • Existing continuous-wave (CW) red light therapies face a "trade-off": low intensity lacks penetration depth, while high intensity risks skin burns.
• Mechanism:Pulsed Light Strategy: The study utilized pulsed 630 nm red light with a 40% duty cycle and a peak intensity of 25 mW/cm².Deep Penetration: Pulsed light achieves better tissue penetration to reach the uterus (approx. 2.5 cm deep) while maintaining a low average intensity (10 mW/cm²) to avoid overheating the skin.Biological Action: It reduces prostaglandin levels, improves local blood circulation, and suppresses pain-conducting nerve fibers, thereby relaxing uterine muscles and reducing pain sensitivity.
  • Pulsed Light Strategy: The study utilized pulsed 630 nm red light with a 40% duty cycle and a peak intensity of 25 mW/cm².
  • Deep Penetration: Pulsed light achieves better tissue penetration to reach the uterus (approx. 2.5 cm deep) while maintaining a low average intensity (10 mW/cm²) to avoid overheating the skin.
  • Biological Action: It reduces prostaglandin levels, improves local blood circulation, and suppresses pain-conducting nerve fibers, thereby relaxing uterine muscles and reducing pain sensitivity.
• Clinical Results:Significant Pain Relief: The average VAS (Visual Analogue Scale) pain score dropped from 6.63 to 3.63 after treatment (p < 0.0001), whereas the placebo group (white light) showed no significant change.High Response Rate: 55% of participants experienced a pain reduction of more than 50%.Quality of Life: Subjects reported improvements in menstrual regularity, reduced abdominal bloating, fewer blood clots, and stabilized mood.Safety: No adverse events or side effects were reported throughout the trial.
  • Significant Pain Relief: The average VAS (Visual Analogue Scale) pain score dropped from 6.63 to 3.63 after treatment (p < 0.0001), whereas the placebo group (white light) showed no significant change.
  • High Response Rate: 55% of participants experienced a pain reduction of more than 50%.
  • Quality of Life: Subjects reported improvements in menstrual regularity, reduced abdominal bloating, fewer blood clots, and stabilized mood.
  • Safety: No adverse events or side effects were reported throughout the trial.
• Conclusion:Pulsed 630 nm LED therapy is a safe and highly effective non-invasive treatment for primary dysmenorrhea.The technology successfully balances therapeutic efficacy with skin safety, offering a promising alternative to pharmacological interventions.
  • Pulsed 630 nm LED therapy is a safe and highly effective non-invasive treatment for primary dysmenorrhea.
  • The technology successfully balances therapeutic efficacy with skin safety, offering a promising alternative to pharmacological interventions.